Hillary L. Copp, MD, MS

Hillary L. Copp, MD, MS

Professor of Urology and Chief of Pediatric Urology

Pediatric Urology Fellowship Director

Education

BS, 1996, University of California, Santa Barbara, CA, Biology

MD, 2002, Penn State University, College of Medicine, Hershey, PA, Medicine

Residency, 2007, University of Virginia, Charlottesville, VA

Fellowship, 2009, Stanford University, Stanford, CA

MS, 2009, Stanford University, Stanford, CA, Epidemiology

Biography

Hillary Copp, MD, MS graduated from the University of California Santa Barbara Summa Cum Laude with a Bachelor of Science in Biological Sciences. She attended medical school at Penn State University College of Medicine. She then completed her urology residency at the University of Virginia in Charlottesville. This was followed by a fellowship in pediatric urology at Stanford University where she concurrently earned a master's degree in Epidemiology. Copp has received numerous awards. She was inducted into the Alpha Omega Alpha National Medical Honor Society and received the Penn State College of Medicine Alumni Endowed Scholarship and the Merck Achievement of Academic Excellence award. She is a graduate of the University of California, San Francisco Coro Leadership Program and the American Urological Association Leadership Program. Dr. Hillary Copp became Chief of Pediatric Urology in 2024.

Clinical Interests

Copp specializes in all aspects of pediatric urologic surgical care. Specifically, her clinical interests include urinary tract infection (UTI), vesicoureteral reflux, hydronephrosis/ureteropelvic junction obstruction, fetal urology, spina bifida, and transitional urology. She performs open, laparoscopic, and endoscopic surgeries. She operates at the UCSF Benioff Children's Hospitals in San Francisco and Oakland, Zuckerberg San Francisco General Hospital, and Marin General Hospital. Copp is a member of the Society for Pediatric Urology, the Society for Fetal Urology, the American Academy of Pediatric Urology, the American Urological Association (AUA), and the Western Section of the AUA. She has served as a member on the Pediatric Vesicoureteral Reflux Clinical Guidelines Panel for the AUA, sits on the executive council for the Society for Pediatric Urology, and is the secretary/treasurer of the Society for Fetal Urology. She also is an appointed member of the Public Education Council and Pediatric Health Committee for the Urology Care Foundation. She continues to serve as a reviewer for several journals including the Journal of Urology, the Journal of Pediatric Urology, and Pediatrics. She has over 40 peer-reviewed scientific articles and multiple textbook chapters and has presented at numerous national and international meetings.

Research Interests

In 2009 Copp joined the faculty in the Department of Urology at UCSF as a participant in the multidisciplinary K12 Urologic Research (KURe) Career Development Program<http://urology.ucsf.edu/research/kure>. Copp’s research focuses on understanding the results of health care practice and intervention, specifically among patients with UTI. She is interested in the complex interplay between antibiotic prophylaxis, adherence, treatment outcomes and antibiotic resistance. She has worked to describe patterns of care surrounding UTI. Her research studies have included investigating admission rates for pyelonephritis in children in the state of California, describing national antibiotic prescribing patterns for UTI, and examining urine testing for UTI management using a large pharmacy claims database. Copp has also completed important work on uropathogen resistance among children with UTI. She used a large dataset that gathers culture data from around the United States called the Surveillance Network to describe national outpatient resistance patterns for UTI. She has recently completed a multi-institutional, international study using individual patient data from previously published randomized controlled trials on UTI prevention with antibiotic prophylaxis among children with vesicoureteral reflux. In addition, she has used data from the NIH sponsored RIVUR and CUTIE trials to study risk factors for bladder and bowel dysfunction among children with UTI; to assess predictors of becoming overweight among children at risk for UTI; and to determine risk factors for non-adherence to antibiotic prophylaxis and how adherence alters the effect of prophylaxis on recurrent UTI and renal scarring.

View my research publications